fda update on semaglutide US approves weight loss drug Wegovy to prevent cardiovascular events What the FDA's update on

By activating GLP-1 receptors in the brain, semaglutide helps reduce appetite, increase feelings of fullness, and ultimately lead to a reduction in calorie intake

Clin Biochem 2003;36:585-90

As Nutrigenomics Coaches we can help coordinate supplements to avoid overlap or contraindications

Ro vs TrumpRx TL;DR: D2C telehealth platforms like Ro and Hims & Hers scaled from high-margin ED generics to even more lucrative GLP-1s, but Trump's TrumpRx platform now threatens to commoditize their obesity business

Those with type 2 diabetes often reduce medication requirements or achieve remission

Collective data on the class effect of DPP-4 inhibitor therapy on beta-cell function revealed that monotherapy and combination therapy improved beta-cell function